Literature DB >> 10623435

Recruitment of primitive peripheral blood cells: synergism of interleukin 12 with interleukin 6 and stromal cell-derived FACTOR-1.

S Grafte-Faure1, C Leveque, E Ketata, P Jean, M Vasse, C Soria, J P Vannier.   

Abstract

In bone marrow, haematopoietic stem cells (HSC) rely on close contact with stromal cells for proliferation and differentiation. Stromal cell-derived factor (SDF-1) is a chemokine produced by bone marrow stromal cells and has been reported to be a chemoattractant for CD34(+)cells. SDF-1 was evaluated for effects on proliferation of both mature and immature human progenitor cells in vitro. Neither proliferation nor maturation of peripheral blood cells was stimulated by SDF-1 alone. Moreover, we have previously demonstrated that 5-fluorouracile (5-FU) resistant HSC require a combination of interleukin 12 (IL-12), IL-6 and SCF for the production of morphologically recognizable clonogenic elements at day 14 in semisolid medium. Our data reported a strong enhancement of the IL-6, IL-12, SCF-induced synergism (172%) by SDF-1 (296.5%). Furthermore, our data suggest that this chemokine alone had no effect on triggering quiescent cells and may preserve these cells from 5-FU cell damage or upregulate early-acting cytokine receptors. Thus, SDF-1 might play a key role in early human haematopoiesis through its potent synergistic effects in combination with early-acting cytokines. These results suggest that a programmed response to sequential cytokine stimulation may be part of a control mechanism required for maintenance of proliferation of primitive HSC. Copyright 2000 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10623435     DOI: 10.1006/cyto.1999.0520

Source DB:  PubMed          Journal:  Cytokine        ISSN: 1043-4666            Impact factor:   3.861


  6 in total

1.  Induction of the chemokine stromal-derived factor-1 following DNA damage improves human stem cell function.

Authors:  T Ponomaryov; A Peled; I Petit; R S Taichman; L Habler; J Sandbank; F Arenzana-Seisdedos; A Magerus; A Caruz; N Fujii; A Nagler; M Lahav; M Szyper-Kravitz; D Zipori; T Lapidot
Journal:  J Clin Invest       Date:  2000-12       Impact factor: 14.808

2.  Interferon gamma has dual potential in inhibiting or promoting survival and growth of hematopoietic progenitors: interactions with stromal cell-derived factor 1.

Authors:  Jin-Hee Hwang; Seong-Woo Kim; Hyo-Jin Lee; Hwan-Jung Yun; Samyong Kim; Deog-Yeon Jo
Journal:  Int J Hematol       Date:  2006-08       Impact factor: 2.490

3.  Mesenchymal stem cell expression of stromal cell-derived factor-1β augments bone formation in a model of local regenerative therapy.

Authors:  Samuel Herberg; Galina Kondrikova; Khaled A Hussein; Maribeth H Johnson; Mohammed E Elsalanty; Xingming Shi; Mark W Hamrick; Carlos M Isales; William D Hill
Journal:  J Orthop Res       Date:  2014-10-28       Impact factor: 3.494

4.  Over-expression of CXCR4 on mesenchymal stem cells augments myoangiogenesis in the infarcted myocardium.

Authors:  Dongsheng Zhang; Guo-Chang Fan; Xiaoyang Zhou; Tiemin Zhao; Zeeshan Pasha; Meifeng Xu; Yi Zhu; Muhammad Ashraf; Yigang Wang
Journal:  J Mol Cell Cardiol       Date:  2007-12-07       Impact factor: 5.000

5.  Total body irradiation is permissive for mesenchymal stem cell-mediated new bone formation following local transplantation.

Authors:  Samuel Herberg; Galina Kondrikova; Khaled A Hussein; Sudharsan Periyasamy-Thandavan; Maribeth H Johnson; Mohammed E Elsalanty; Xingming Shi; Mark W Hamrick; Carlos M Isales; William D Hill
Journal:  Tissue Eng Part A       Date:  2014-12       Impact factor: 3.845

6.  Deficiency in Fpr2 results in reduced numbers of Lin-cKit+Sca1+ myeloid progenitor cells.

Authors:  Keqiang Chen; Peng Tang; Zhiyao Bao; Tianzhen He; Yi Xiang; Wanghua Gong; Teizo Yoshimura; Yingying Le; Lino Tessarollo; Xin Chen; Ji Ming Wang
Journal:  J Biol Chem       Date:  2018-07-17       Impact factor: 5.157

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.